Compare Two Stocks
Valuation, growth, earnings reaction and guidance credibility, side by sideWSTWest Pharmaceutical Services
FinDog View：Neutral
| Metric | AMGN | WST |
|---|
| Close | 376.35 | 362.01 |
| Market Cap | $203B | $23.9B |
| 1M | −10.26% | +4.44% |
| P/E (TTM) | 23.3 | 43.1 |
| Forward P/E | 16.9 | 36.0 |
| P/E 5-Yr Percentile | 27 | 49 |
| P/S | 5.4 | 7.3 |
| P/B | 17.4 | 8.2 |
| Dividend Yield | 3.21% | 0.33% |
| Latest Quarter Revenue | $10.1B | $872M |
| Revenue YoY | +9.5% | +13.8% |
| Gross Margin | 72.0% | 37.7% |
| Latest Quarter EPS | 4.37 | 2.15 |
| Avg Post-Earnings Move | ±5.2% | ±3.7% |
| EPS Beat Rate | — | — |
| Guidance Hit Rate | — | 1 / 1 |
| Shareholder Yield | 2.60% | 2.16% |
| 90-Day Net Insider Buying | −$4.1M | −$5.4M |
AMGN · Revenue, Last 8 Quarters ($B)
WST · Revenue, Last 8 Quarters ($B)
